Abstract Body

Virus-specific CD8+ T cells play a central role in HIV-1 natural controllers. They have been shown to display a distinct memory program that confers them stemness properties, high survival, polyfunctionality, proliferative capacity, metabolic plasticity, and antiviral potential. The development and maintenance of such qualities by memory CD8+ T cells thus appear crucial to achieve natural HIV-1 control. We hypothesized that targeting CD8+ T cell signaling pathways, such as Wnt/TCF-1 and mTORC, related to the maintenance of a stem-like memory profile, would reprogram the functional capacity of cells derived from HIV-1 non-controllers towards superior functional capacity.

Purified CD8+ T cells from people without HIV-1 or HIV non-controllers were treated ex vivo for 12 hs with a GSK3 inhibitor (hereinafter referred to as reprogramming), or free vehicle as control, followed by phenotypic, transcriptional, metabolic, and functional analyses upon polyclonal, antigen-specific, or cytokine stimulation.

Treatment of HIV-specific CD8+ T cells from HIV non-controller individuals with the GSK3 inhibitor promoted the enrichment of less differentiated memory subsets, including TCF-1+ stem-like subsets (median [range] 0% [0-16.28] vs 32.16% [20.65-47.27] stem-like memory cells, P=0.03). Such reprogrammed cells were characterized by enhanced survival and expansion capacity upon stimulation (median [range] 0.068% [0.016-0.13] vs 0.11% [0.039-0.44], Gag-responding cells; P=0.001), and by restored metabolic plasticity and decreased mTORC1 dependency. Moreover, reprogrammed cells had superior polyfunctionality (~40-fold increase in the % of IFN-?+ TNF-?+ IL-2+ Granzyme B+ Gag-responding CD8+ T cells upon reprogramming). They also expressed higher levels of IL-7 and IL-15 receptors and responded better to these ?-chain cytokines (median [range] 30.8% [22.5-47.5] vs 55.95% [31.5-69.1], CFSElo HIV Dextramer+ CD8+ T cells; P=0.007), revealing their enhanced potential for homeostatic self-renewal.

Ex vivo treatment of virus-specific CD8+ T cells from non-controllers with a GSK3 inhibitor resulted in reprogramming and acquisition of phenotypic, transcriptional, metabolic, and functional attributes associated with natural control of HIV-1. Thus, such CD8+ T cell reprogramming, combined with other available immunomodulators, might represent a promising strategy for adoptive cell therapy in the search for an HIV-1 cure.